---
document_datetime: 2023-09-21 20:04:10
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/daurismo-epar-all-authorised-presentation_en.pdf
document_name: daurismo-epar-all-authorised-presentation_en.pdf
version: success
processing_time: 0.8778898
conversion_datetime: 2025-12-15 06:07:21.95374
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging     | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-------------------------|-------------|
| EU/1/20/1451/001 | Daurismo          | 25 mg      | Film-coated tablet    | Oral Use                  | Bottle (HDPE)           | 60 tablets  |
| EU/1/20/1451/002 | Daurismo          | 25 mg      | Film-coated tablet    | Oral Use                  | Blister (PVC/Aluminium) | 60 tablets  |
| EU/1/20/1451/003 | Daurismo          | 100 mg     | Film-coated tablet    | Oral Use                  | Bottle (HDPE)           | 30 tablets  |
| EU/1/20/1451/004 | Daurismo          | 100 mg     | Film-coated tablet    | Oral Use                  | Blister (PVC/Aluminium) | 30 tablets  |